Cargando…

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease

Serum lipid abnormalities (dyslipidemias) are major risk factors for cardiovascular disease in type 2 diabetes mellitus. Recent findings provide new evidence that dyslipidemia characterized by elevated triglycerides and non‐high‐density lipoprotein cholesterol levels with a decreased high‐density li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuzaka, Takashi, Shimano, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	JDI Updates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232277/ https://www.ncbi.nlm.nih.gov/pubmed/32232972 http://dx.doi.org/10.1111/jdi.13258

Ejemplares similares

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019)

Recent updates and future perspectives on gestational diabetes mellitus: An important public health challenge
por: Chu, Leo Check Hei, et al.
Publicado: (2021)

New prospects for incretin‐related drugs in the treatment of type 2 diabetes
por: Kimura, Tomohiko, et al.
Publicado: (2020)

New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020)

Diabetic kidney disease: Its current trends and future therapeutic perspectives
por: Koya, Daisuke
Publicado: (2019)

Cardiovascular disease in patients with type 2 diabetes
por: Jeon, Ja Young, et al.
Publicado: (2022)

One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches
por: Aso, Yoshimasa
Publicado: (2021)

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia
por: Seino, Yusuke, et al.
Publicado: (2019)

Recent evidence in the etiology and treatment for diabetic kidney disease
por: Shikata, Kenichi
Publicado: (2020)

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
por: Lin, Kuan‐Yu, et al.
Publicado: (2021)

Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
por: Nakamura, Toshihiro, et al.
Publicado: (2020)

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
por: Fujita, Yoshihito, et al.
Publicado: (2019)

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
por: Hosokawa, Yusei, et al.
Publicado: (2020)

Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β‐cell dysfunction
por: Watada, Hirotaka
Publicado: (2020)

Obesity, metabolic syndrome and bariatric surgery: A narrative review
por: Jia, Weiping
Publicado: (2020)

Blood glucose control: Where are we?
por: Lee, Moon‐Kyu
Publicado: (2021)

Impaired insulin secretion and related factors in East Asian individuals
por: Nakamura, Akinobu, et al.
Publicado: (2021)

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

New liver–β‐cell axis that controls insulin secretory capacity
por: Matsuzaka, Takashi, et al.
Publicado: (2014)

GLUT12: a second insulin‐responsive glucose transporters as an emerging target for type 2 diabetes
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
por: Martin, Anna, et al.
Publicado: (2022)

Scarring in Alcoholic Liver Disease: New Insights and Emerging Therapies
por: Friedman, Scott L.
Publicado: (1997)

Apoptosis and Necrosis: Two Types of Cell Death in Alcoholic Liver Disease
por: Nanji, Amin A., et al.
Publicado: (1997)

Liver Transplantation for Alcoholics with Terminal Liver Disease
por: Van Thiel, David H.
Publicado: (1996)

Cytokines and Alcoholic Liver Disease
por: McClain, Craig J., et al.
Publicado: (1997)

Oxidative Stress and Alcoholic Liver Disease
por: Fernández-Checa, Jose C., et al.
Publicado: (1997)

Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
por: Suzuki-Kemuriyama, Noriko, et al.
Publicado: (2016)

Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study
por: Naghipour, Amirhossein, et al.
Publicado: (2023)

Relationship between dyslipidemia and diabetic retinopathy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
por: Li, Zhaoping, et al.
Publicado: (2023)

Liver Transplantation and Alcoholism Rehabilitation
por: Beresford, Thomas
Publicado: (1994)

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Rho‐associated, coiled‐coil‐containing protein kinase 1 as a new player in the regulation of hepatic lipogenesis
por: Miyamoto, Takafumi, et al.
Publicado: (2019)

Insulin‐dependent and ‐independent regulation of sterol regulatory element‐binding protein‐1c
por: Matsuzaka, Takashi, et al.
Publicado: (2013)

Molecular mechanisms involved in hepatic steatosis and insulin resistance
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7nq3nbfm9mhqc9525ub5d28hvg